GlassScriptPhysician profile
Nathan C Dean
NPI 1063437770
$2,775.84
in general payments reported to CMS, 2019-2025
12 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.47 · 2020: $13.65 · 2021: $2,425 · 2023: $22.38 · 2024: $179 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.34 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofire Diagnostics, LLC | $1,300.00 | 2021 | |
| Merck Sharp & Dohme LLC | $1,125.00 | 2021 | |
| Mannkind Corporation | $129.89 | 2024 | |
| Alcresta Therapeutics, INC. | $49.19 | 2024 | Relizorb |
| Baxter Healthcare | $48.09 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Astrazeneca Pharmaceuticals LP | $24.69 | 2025 | Tezspire |
| Electromed, INC. | $23.47 | 2019 | |
| Viatris Specialty LLC | $22.90 | 2025 | Yupelri |
| Genzyme Corporation | $21.58 | 2025 | |
| Insmed, INC. | $17.38 | 2025 | |
| Chiesi USA, INC. | $13.65 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.